Land: Ierland
Taal: Engels
Bron: HPRA (Health Products Regulatory Authority)
QUININE SULFATE
Actavis UK Limited
P01BC01
QUININE SULFATE
300 Milligram
Coated Tablets
Product subject to prescription which may be renewed (B)
Methanolquinolines
Authorised
1985-07-04
Quinine Sulphate 300 mg Coated Tablets. V008 - QRD Update + ADR PA176/27/2 131- PIL text V008 Jun 2015 PACKAGE LEAFLET: INFORMATION FOR THE USER QUININE SULPHATE 300 MG COATED TABLETS Quinine Sulphate READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This include any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. 1 WHAT QUININE SULPHATE IS AND WHAT IT IS USED FOR 2. 2 WHAT YOU NEED TO KNOW BEFORE YOU TAKE QUININE SULPHATE 3. 3 HOW TO TAKE QUININE SULPHATE 4. 4 POSSIBLE SIDE EFFECTS 5. 5 HOW TO STORE QUININE SULPHATE 6. 6 CONTENTS OF THE PACK AND OTHER INFORMATION 1. WHAT QUININE SULPHATE IS AND WHAT IT IS USED FOR Quinine sulphate belongs to a group of medicines called anti-protozoal agents and they are used to: • treat malaria • treat and prevent nocturnal (night time) leg cramps in the adults and the elderly when sleep is regularly disrupted. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE QUININE SULPHATE DO NOT TAKE QUININE SULPHATE: • if you are allergic to quinine sulphate or any of the other ingredients of this medicine ( listed in section 6) • if you have BLOOD IN YOUR URINE • if you have RINGING OR BUZZING IN YOUR EARS (tinnitus) • if you have PROBLEMS WITH YOUR EYES or difficulty seeing • if Lees het volledige document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Quinine Sulphate 300mg Coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 300 mg Quinine Sulphate. Excipients with known effect: each tablet contains 231.45mg sucrose. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Coated tablet. White, circular, biconvex, sugar-coated tablets. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS 1. In the treatment of malignant tertian malaria including treatment of chloroquine resistant malaria. 2. Treatment and prevention of nocturnal leg cramps in adults and the elderly, when cramps cause regular disruption of sleep (see section 4.2 and 4.4 and 4.8). 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _For the treatment of falciparum malaria:_ _Adults (including elderly) and children over 12 years:_ 600 mg every eight hours for 7 days. The dose may depend upon the size of the patient, severity of infection, and evidence of renal or liver disease (when the intervals should be increased), due to a prolonged half-life of the drug. If Quinine resistance is known or suspected on completion of the course additional treatment may be given. This may be one of the following: 1. doxycycline 200 mg daily (as a single dose or in two divided doses) for at least 7 days. 2. clindamycin 300 mg four times daily for 5 days. _Children under 12 years:_ 10 mg/kg every eight hours for 7 days. _For the treatment and prevention of nocturnal leg cramps:_ _Adults (including elderly):_ 300 mg at bedtime. The maximum dose is 300 mg. A reduction in frequency of leg cramps may take up to 4 weeks to become apparent. Patients should be monitored closely by their GPs during the early stages of treatment for adverse effects as well as for ben Lees het volledige document